|
1YUC
Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to Phospholipid and a Fragment of Human SHP
提交 2005-02-13
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 C
15–28(14 aa)
片段:NR Box1
|
未记录
|
EPH L-ALPHA-PHOSPHATIDYL-BETA-OLEOYL-GAMMA-PALMITOYL-PHOSPHATIDYLETHANOLAMINE × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.4;9.5%-15% PEG 3350, 5% glycerol, and 50 mM Bis-Tris, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 100K
|
分辨率 1.90 Å
R-free 0.248
|
|
1YUC
Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to Phospholipid and a Fragment of Human SHP
提交 2005-02-13
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 D
15–28(14 aa)
片段:NR Box1
|
未记录
|
EPH L-ALPHA-PHOSPHATIDYL-BETA-OLEOYL-GAMMA-PALMITOYL-PHOSPHATIDYLETHANOLAMINE × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.4;9.5%-15% PEG 3350, 5% glycerol, and 50 mM Bis-Tris, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 100K
|
分辨率 1.90 Å
R-free 0.248
|
|
1YUC
Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to Phospholipid and a Fragment of Human SHP
提交 2005-02-13
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 3
蛋白异源复合物
异源复合物;蛋白 × 4
PDB 声明:tetrameric
|
链 C
15–28(14 aa)
片段:NR Box1
链 D
15–28(14 aa)
片段:NR Box1
|
未记录
|
EPH L-ALPHA-PHOSPHATIDYL-BETA-OLEOYL-GAMMA-PALMITOYL-PHOSPHATIDYLETHANOLAMINE × 2
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.4;9.5%-15% PEG 3350, 5% glycerol, and 50 mM Bis-Tris, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 100K
|
分辨率 1.90 Å
R-free 0.248
|
|
1YUC
Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to Phospholipid and a Fragment of Human SHP
提交 2005-02-13
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 4
蛋白异源复合物
异源复合物;蛋白 × 4
PDB 声明:tetrameric
|
链 C
15–28(14 aa)
片段:NR Box1
链 D
15–28(14 aa)
片段:NR Box1
|
未记录
|
EPH L-ALPHA-PHOSPHATIDYL-BETA-OLEOYL-GAMMA-PALMITOYL-PHOSPHATIDYLETHANOLAMINE × 2
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.4;9.5%-15% PEG 3350, 5% glycerol, and 50 mM Bis-Tris, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 100K
|
分辨率 1.90 Å
R-free 0.248
|
|
2Q3Y
Ancestral Corticiod Receptor in Complex with DOC
提交 2007-05-30
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 B
18–27(10 aa)
片段:hSHP NR Box1
|
未记录
|
1CA DESOXYCORTICOSTERONE × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.4;298 K;9.5%-15% PEG 3350, 5% glycerol, and 50 mM Bis-Tris, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
分辨率 2.40 Å
R-free 0.240
|
|
2Z4J
Crystal structure of AR LBD with SHP peptide NR Box 2
提交 2007-06-19
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 B
115–124(10 aa)
片段:residues 115-124
|
未记录
|
DHT 5-ALPHA-DIHYDROTESTOSTERONE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 7;298 K;0.1M Bis-Tris Propane, 1.2M Potassium Sodium Tartrate tetrahydrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K
|
分辨率 2.60 Å
R-free 0.234
|
|
4DOR
Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, in its apo State Bound to a Fragment of Human SHP Box1
提交 2012-02-10
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 4
PDB 声明:tetrameric
|
链 C
15–28(14 aa)
片段:UNP residues 15-28
链 D
15–28(14 aa)
片段:UNP residues 15-28
|
未记录
|
EPH L-ALPHA-PHOSPHATIDYL-BETA-OLEOYL-GAMMA-PALMITOYL-PHOSPHATIDYLETHANOLAMINE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.4;298 K;9.5%-15% PEG 3350, 5% glycerol, and 50 mM Bis-Tris, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
分辨率 1.90 Å
R-free 0.220
|
|
4DOR
Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, in its apo State Bound to a Fragment of Human SHP Box1
提交 2012-02-10
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 C
15–28(14 aa)
片段:UNP residues 15-28
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.4;298 K;9.5%-15% PEG 3350, 5% glycerol, and 50 mM Bis-Tris, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
分辨率 1.90 Å
R-free 0.220
|
|
4DOR
Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, in its apo State Bound to a Fragment of Human SHP Box1
提交 2012-02-10
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 3
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 D
15–28(14 aa)
片段:UNP residues 15-28
|
未记录
|
EPH L-ALPHA-PHOSPHATIDYL-BETA-OLEOYL-GAMMA-PALMITOYL-PHOSPHATIDYLETHANOLAMINE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.4;298 K;9.5%-15% PEG 3350, 5% glycerol, and 50 mM Bis-Tris, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
分辨率 1.90 Å
R-free 0.220
|
|
4ONI
Structure of Human Orphan Receptor LRH1 bound to two bacterial phospholipids
提交 2014-01-28
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 C
12–30(19 aa)
片段:NR Box1, UNP residues 12-30
|
未记录
|
EPH L-ALPHA-PHOSPHATIDYL-BETA-OLEOYL-GAMMA-PALMITOYL-PHOSPHATIDYLETHANOLAMINE × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 6.4;298 K;20-30% PEG 3350, Bis Tris, 5% glycerol, pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
分辨率 1.80 Å
R-free 0.202
|
|
4ONI
Structure of Human Orphan Receptor LRH1 bound to two bacterial phospholipids
提交 2014-01-28
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 D
12–30(19 aa)
片段:NR Box1, UNP residues 12-30
|
未记录
|
P6L (2S)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(6E)-HEXADEC-6-ENOYLOXY]PROPYL (8E)-OCTADEC-8-ENOATE × 1
PG4 TETRAETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 6.4;298 K;20-30% PEG 3350, Bis Tris, 5% glycerol, pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
分辨率 1.80 Å
R-free 0.202
|
|
6W9M
Structure of the Ancestral Glucocorticoid Receptor 2 ligand binding domain in complex with vamorolone and SHP coregulator fragment
提交 2020-03-23
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 B
17–27(11 aa)
片段:eleven-residue fragment
|
未记录
|
TUV vamorolone × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION;pH 8.5;289.15 K;25% PEG 300 and 0.1 M Tris pH 8.5
|
分辨率 1.59 Å
R-free 0.220
|
|
7YXC
Crystal structure of WT AncGR2-LBD bound to dexamethasone and SHP coregulator fragment
提交 2022-02-15
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 R
17–27(11 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
PG4 TETRAETHYLENE GLYCOL × 1
CO3 CARBONATE ION × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293.15 K;85 mM sodium cacodylate trihydrate, pH 6.5, 0.17 M sodium acetate trihydrate, 25.5% (w/v) PEG8000, 15% (v/v) glycerol
|
分辨率 2.25 Å
R-free 0.245
|
|
7YXD
Crystal structure of WT AncGR2-LBD bound to dexamethasone and SHP coregulator fragment
提交 2022-02-15
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 C
17–28(12 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8;293.15 K;0.1 M Tris-HCl, pH 8.0, 0.2 M sodium chloride, 2.0 M ammonium sulfate
|
分辨率 2.30 Å
R-free 0.221
|
|
7YXD
Crystal structure of WT AncGR2-LBD bound to dexamethasone and SHP coregulator fragment
提交 2022-02-15
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 F
17–28(12 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8;293.15 K;0.1 M Tris-HCl, pH 8.0, 0.2 M sodium chloride, 2.0 M ammonium sulfate
|
分辨率 2.30 Å
R-free 0.221
|
|
7YXD
Crystal structure of WT AncGR2-LBD bound to dexamethasone and SHP coregulator fragment
提交 2022-02-15
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 3
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 J
17–28(12 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8;293.15 K;0.1 M Tris-HCl, pH 8.0, 0.2 M sodium chloride, 2.0 M ammonium sulfate
|
分辨率 2.30 Å
R-free 0.221
|
|
7YXD
Crystal structure of WT AncGR2-LBD bound to dexamethasone and SHP coregulator fragment
提交 2022-02-15
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 4
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 N
17–28(12 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8;293.15 K;0.1 M Tris-HCl, pH 8.0, 0.2 M sodium chloride, 2.0 M ammonium sulfate
|
分辨率 2.30 Å
R-free 0.221
|
|
7YXO
Crystal structure of WT AncGR2-LBD bound to dexamethasone and SHP coregulator fragment
提交 2022-02-16
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 B
17–27(11 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
CPS 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1-PROPANESULFONATE × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8;293.15 K;0.1 M Tris-HCl, pH 8.0, 0.2 M sodium chloride, 2.0 M ammonium sulfate
|
分辨率 2.99 Å
R-free 0.280
|
|
7YXO
Crystal structure of WT AncGR2-LBD bound to dexamethasone and SHP coregulator fragment
提交 2022-02-16
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 D
17–27(11 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
CPS 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1-PROPANESULFONATE × 1
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8;293.15 K;0.1 M Tris-HCl, pH 8.0, 0.2 M sodium chloride, 2.0 M ammonium sulfate
|
分辨率 2.99 Å
R-free 0.280
|
|
7YXO
Crystal structure of WT AncGR2-LBD bound to dexamethasone and SHP coregulator fragment
提交 2022-02-16
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 3
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 F
17–27(11 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8;293.15 K;0.1 M Tris-HCl, pH 8.0, 0.2 M sodium chloride, 2.0 M ammonium sulfate
|
分辨率 2.99 Å
R-free 0.280
|
|
7YXR
Crystal structure of mutant AncGR2-LBD (Y545A) bound to dexamethasone and SHP coregulator fragment
提交 2022-02-16
|
构建体不同
配体/离子不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 R
17–28(12 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 7;293.15 K;0.1 M PIPES, pH 7.0, 0.1 M ammonium acetate, 2.5 M sodium formate
|
分辨率 2.50 Å
R-free 0.224
|
|
7YXR
Crystal structure of mutant AncGR2-LBD (Y545A) bound to dexamethasone and SHP coregulator fragment
提交 2022-02-16
|
构建体不同
配体/离子不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 S
17–28(12 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
FMT FORMIC ACID × 3
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 7;293.15 K;0.1 M PIPES, pH 7.0, 0.1 M ammonium acetate, 2.5 M sodium formate
|
分辨率 2.50 Å
R-free 0.224
|
|
9HDF
Glucocorticoid Receptor Ligand Binding Domain in complex with dexamethasone
提交 2024-11-12
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 a
15–29(15 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
CAC CACODYLATE ION × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
GOL GLYCEROL × 2
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.085 M sodium cacodylate trihydrate, pH 6.5, 0.17 M ammonium sulfate, 25.5% (w/v) polyethylene glycol 8000 and 15% (v/v) glycerol
|
分辨率 2.78 Å
R-free 0.244
|
|
9HDF
Glucocorticoid Receptor Ligand Binding Domain in complex with dexamethasone
提交 2024-11-12
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 10
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 j
15–29(15 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
GOL GLYCEROL × 3
SO4 SULFATE ION × 1
CL CHLORIDE ION × 1
IMD IMIDAZOLE × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.085 M sodium cacodylate trihydrate, pH 6.5, 0.17 M ammonium sulfate, 25.5% (w/v) polyethylene glycol 8000 and 15% (v/v) glycerol
|
分辨率 2.78 Å
R-free 0.244
|
|
9HDF
Glucocorticoid Receptor Ligand Binding Domain in complex with dexamethasone
提交 2024-11-12
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 11
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 k
15–29(15 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
CAC CACODYLATE ION × 1
GOL GLYCEROL × 2
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.085 M sodium cacodylate trihydrate, pH 6.5, 0.17 M ammonium sulfate, 25.5% (w/v) polyethylene glycol 8000 and 15% (v/v) glycerol
|
分辨率 2.78 Å
R-free 0.244
|
|
9HDF
Glucocorticoid Receptor Ligand Binding Domain in complex with dexamethasone
提交 2024-11-12
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 12
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 l
15–29(15 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
GOL GLYCEROL × 2
CL CHLORIDE ION × 1
PG4 TETRAETHYLENE GLYCOL × 1
IMD IMIDAZOLE × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.085 M sodium cacodylate trihydrate, pH 6.5, 0.17 M ammonium sulfate, 25.5% (w/v) polyethylene glycol 8000 and 15% (v/v) glycerol
|
分辨率 2.78 Å
R-free 0.244
|
|
9HDF
Glucocorticoid Receptor Ligand Binding Domain in complex with dexamethasone
提交 2024-11-12
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 13
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 m
15–29(15 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
CAC CACODYLATE ION × 1
GOL GLYCEROL × 1
CL CHLORIDE ION × 1
IMD IMIDAZOLE × 1
PEG DI(HYDROXYETHYL)ETHER × 1
PGE TRIETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.085 M sodium cacodylate trihydrate, pH 6.5, 0.17 M ammonium sulfate, 25.5% (w/v) polyethylene glycol 8000 and 15% (v/v) glycerol
|
分辨率 2.78 Å
R-free 0.244
|
|
9HDF
Glucocorticoid Receptor Ligand Binding Domain in complex with dexamethasone
提交 2024-11-12
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 14
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 n
15–29(15 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
GOL GLYCEROL × 1
CL CHLORIDE ION × 1
IMD IMIDAZOLE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.085 M sodium cacodylate trihydrate, pH 6.5, 0.17 M ammonium sulfate, 25.5% (w/v) polyethylene glycol 8000 and 15% (v/v) glycerol
|
分辨率 2.78 Å
R-free 0.244
|
|
9HDF
Glucocorticoid Receptor Ligand Binding Domain in complex with dexamethasone
提交 2024-11-12
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 15
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 o
15–29(15 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
CAC CACODYLATE ION × 1
GOL GLYCEROL × 1
IMD IMIDAZOLE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.085 M sodium cacodylate trihydrate, pH 6.5, 0.17 M ammonium sulfate, 25.5% (w/v) polyethylene glycol 8000 and 15% (v/v) glycerol
|
分辨率 2.78 Å
R-free 0.244
|
|
9HDF
Glucocorticoid Receptor Ligand Binding Domain in complex with dexamethasone
提交 2024-11-12
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 16
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 p
15–29(15 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.085 M sodium cacodylate trihydrate, pH 6.5, 0.17 M ammonium sulfate, 25.5% (w/v) polyethylene glycol 8000 and 15% (v/v) glycerol
|
分辨率 2.78 Å
R-free 0.244
|
|
9HDF
Glucocorticoid Receptor Ligand Binding Domain in complex with dexamethasone
提交 2024-11-12
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 b
15–29(15 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
GOL GLYCEROL × 1
SO4 SULFATE ION × 1
CL CHLORIDE ION × 3
PG4 TETRAETHYLENE GLYCOL × 1
IMD IMIDAZOLE × 3
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.085 M sodium cacodylate trihydrate, pH 6.5, 0.17 M ammonium sulfate, 25.5% (w/v) polyethylene glycol 8000 and 15% (v/v) glycerol
|
分辨率 2.78 Å
R-free 0.244
|
|
9HDF
Glucocorticoid Receptor Ligand Binding Domain in complex with dexamethasone
提交 2024-11-12
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 3
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 c
15–29(15 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
GOL GLYCEROL × 2
SO4 SULFATE ION × 2
CL CHLORIDE ION × 1
IMD IMIDAZOLE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.085 M sodium cacodylate trihydrate, pH 6.5, 0.17 M ammonium sulfate, 25.5% (w/v) polyethylene glycol 8000 and 15% (v/v) glycerol
|
分辨率 2.78 Å
R-free 0.244
|
|
9HDF
Glucocorticoid Receptor Ligand Binding Domain in complex with dexamethasone
提交 2024-11-12
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 4
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 d
15–29(15 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
CAC CACODYLATE ION × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
CL CHLORIDE ION × 1
PG4 TETRAETHYLENE GLYCOL × 1
IMD IMIDAZOLE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.085 M sodium cacodylate trihydrate, pH 6.5, 0.17 M ammonium sulfate, 25.5% (w/v) polyethylene glycol 8000 and 15% (v/v) glycerol
|
分辨率 2.78 Å
R-free 0.244
|
|
9HDF
Glucocorticoid Receptor Ligand Binding Domain in complex with dexamethasone
提交 2024-11-12
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 5
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 e
15–29(15 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
CAC CACODYLATE ION × 1
GOL GLYCEROL × 3
CL CHLORIDE ION × 1
IMD IMIDAZOLE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.085 M sodium cacodylate trihydrate, pH 6.5, 0.17 M ammonium sulfate, 25.5% (w/v) polyethylene glycol 8000 and 15% (v/v) glycerol
|
分辨率 2.78 Å
R-free 0.244
|
|
9HDF
Glucocorticoid Receptor Ligand Binding Domain in complex with dexamethasone
提交 2024-11-12
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 6
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 f
15–29(15 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
CL CHLORIDE ION × 1
IMD IMIDAZOLE × 1
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.085 M sodium cacodylate trihydrate, pH 6.5, 0.17 M ammonium sulfate, 25.5% (w/v) polyethylene glycol 8000 and 15% (v/v) glycerol
|
分辨率 2.78 Å
R-free 0.244
|
|
9HDF
Glucocorticoid Receptor Ligand Binding Domain in complex with dexamethasone
提交 2024-11-12
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 7
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 g
15–29(15 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.085 M sodium cacodylate trihydrate, pH 6.5, 0.17 M ammonium sulfate, 25.5% (w/v) polyethylene glycol 8000 and 15% (v/v) glycerol
|
分辨率 2.78 Å
R-free 0.244
|
|
9HDF
Glucocorticoid Receptor Ligand Binding Domain in complex with dexamethasone
提交 2024-11-12
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 8
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 h
15–29(15 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
CAC CACODYLATE ION × 1
PG4 TETRAETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.085 M sodium cacodylate trihydrate, pH 6.5, 0.17 M ammonium sulfate, 25.5% (w/v) polyethylene glycol 8000 and 15% (v/v) glycerol
|
分辨率 2.78 Å
R-free 0.244
|
|
9HDF
Glucocorticoid Receptor Ligand Binding Domain in complex with dexamethasone
提交 2024-11-12
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 9
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 i
15–29(15 aa)
|
未记录
|
DEX DEXAMETHASONE × 1
CAC CACODYLATE ION × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
GOL GLYCEROL × 1
IMD IMIDAZOLE × 1
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.085 M sodium cacodylate trihydrate, pH 6.5, 0.17 M ammonium sulfate, 25.5% (w/v) polyethylene glycol 8000 and 15% (v/v) glycerol
|
分辨率 2.78 Å
R-free 0.244
|